Comparative performance of predictors of death from thin (≤ 1·0 mm) melanoma (Editor)

View/Open
File version
Accepted Manuscript (AM)
Author(s)
Claeson, M
Baade, P
Marchetti, M
Brown, S
Soyer, HP
Smithers, BM
Green, AC
Whiteman, DC
Khosrotehrani, K
Griffith University Author(s)
Year published
2021
Metadata
Show full item record
Abstract
Dear Editor, Despite overall favourable prognosis, thin (≤ 1·0 mm) cutaneous melanomas account for 23% of melanoma deaths in the high-risk general population of Queensland, Australia (2005–2009), because of the sheer volume of disease. The prospect of adjuvant systemic therapy has increased the focus on identifying patients with thin melanoma who are at high risk of death, such as through gene expression profiling (GEP), sentinel lymph node biopsy (SLNB) or prognostic models.
Journal Title
British Journal of Dermatology
DOI
Copyright Statement
© 2021 British Association of Dermatologists. This is the peer reviewed version of the following article: Comparative performance of predictors of death from thin (≤ 1·0 mm) melanoma (Editor), British Journal of Dermatology, 2021, which has been published in final form at https://doi.org/10.1111/bjd.20480. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving (http://olabout.wiley.com/WileyCDA/Section/id-828039.html)
Note
This publication has been entered as an advanced online version in Griffith Research Online.
Subject
Clinical sciences
Oncology and carcinogenesis
Publication URI
Collection